Related Experiment Video
Updated: Sep 27, 2025

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Amending the Law for Licensing Medical Practitioners of China in 2021: A Commentary
Chengxiang Tang1,2, Jiayi Jiang2,3, Yuanyuan Gu1
1Macquarie University Centre for the Health Economy, Macquarie Business School, Macquarie University, NSW, Australia.
Abstract:
The Law for Licensing Medical Practitioners of the People's Republic of China, enacted in 1999, was amended in 2021. This commentary reviews the key points of the amendment and raises doubts as to one of its points. Specifically, we argue that the minimum education level required to take the physicians' licensing examination should be set to completion of a bachelor degree, instead of a vocational diploma or junior college graduation as in the 2021 amendment. China adopted a system of multi-tiered medical education more than 70 years ago. This policy has resulted in a threshold of entry-level medical education far below the global standards. The highly heterogeneous education background of physicians in China has led to low standards of practicing physicians, which in turn have significantly negative impacts on the health care market. We illustrate changes over time in the educational distribution and regional distribution of practicing physicians in China, and present reasons to improve entry-level educational standards, by setting the physician licensing threshold at an appropriate level. This will not only improve the overall quality of physicians but will also help address equity and efficiency issues in the health care market.
More Related Videos
Related Concept Videos
Standards of Care I
CRISPR
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Standards of Care II
Drug Regulation

